Gain insight from Nicholas Hall, the Consumer Healthcare Products Association, and Catalent into the performance of the OTC market, some of the innovation trends and opportunities that are emerging, and the impact of OTC monograph reform on future developments. Live: Tuesday, May 5, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after airing until May 5, 2021 Register free
Webinar Date/Time: Thu, Apr 6, 2023 11:00 AM EDT
Light obscuration testing is the preferred method of sub-visible particle quantification but is not suitable for every preparation.
Light obscuration testing is the preferred method of sub-visible particle quantification but is not suitable for every preparation.
Light obscuration testing is the preferred method of sub-visible particle quantification but is not suitable for every preparation.
A well-defined contamination control program is essential to maintain quality through aseptic manufacture of parenteral drug products.
A well-defined contamination control program is essential to maintain quality through aseptic manufacture of parenteral drug products.
FDA’s new guidance on in-vitro permeation test studies published in October 2022 gives technical and statistical requirements for conducting these tests to compare topical generic drugs with their reference products.